Medipharm Labs Corp LABS

TOR: LABS | ISIN: CA58504D1006   14/11/2024
0,070 CAD (-12,50%)
(-12,50%)   14/11/2024

14 augustus 2024 · MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve · Persbericht

13 augustus 2024 · /R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/ · Persbericht

8 augustus 2024 · MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results · Persbericht

26 juni 2024 · MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders · Persbericht

20 juni 2024 · MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols · Persbericht

15 mei 2024 · MediPharm Labs Reports First Quarter Results · Persbericht

8 mei 2024 · MediPharm Labs Sets Date to Report First Quarter 2024 Financial Results · Persbericht

27 maart 2024 · MediPharm Labs Provides Conference Call Recording Details · Persbericht

27 maart 2024 · MediPharm Labs Reports Fourth Quarter and Full Year Results · Persbericht

25 maart 2024 · MediPharm Labs Provides Update on German Cannabis Legalization · Persbericht

22 maart 2024 · MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results · Persbericht

7 februari 2024 · MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority · Persbericht

22 december 2023 · MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program · Persbericht

8 november 2023 · MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results · Persbericht

25 oktober 2023 · MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash · Persbericht

2 oktober 2023 · MediPharm Labs Settles an Outstanding Claim for $9M · Persbericht

27 september 2023 · MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market · Persbericht

20 september 2023 · MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement · Persbericht

5 september 2023 · MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million · Persbericht

31 augustus 2023 · MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients · Persbericht

Mijn selecties